BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19252134)

  • 1. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.
    Pezzolesi MG; Poznik GD; Mychaleckyj JC; Paterson AD; Barati MT; Klein JB; Ng DP; Placha G; Canani LH; Bochenski J; Waggott D; Merchant ML; Krolewski B; Mirea L; Wanic K; Katavetin P; Kure M; Wolkow P; Dunn JS; Smiles A; Walker WH; Boright AP; Bull SB; ; Doria A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
    Diabetes; 2009 Jun; 58(6):1403-10. PubMed ID: 19252134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of associations between single nucleotide polymorphisms in the FRMD3 and CARS genes and diabetic nephropathy in a Kuwaiti population.
    Al-waheeb S; Alwohhaib M; Abdelghani A; Al-Sharrah S; Al-Shafey E; Al-Sahow A; Alyatama N; Dashti AA; Hussain N
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes.
    Maeda S; Araki S; Babazono T; Toyoda M; Umezono T; Kawai K; Imanishi M; Uzu T; Watada H; Suzuki D; Kashiwagi A; Iwamoto Y; Kaku K; Kawamori R; Nakamura Y
    Diabetes; 2010 Aug; 59(8):2075-9. PubMed ID: 20460425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.
    Rogus JJ; Poznik GD; Pezzolesi MG; Smiles AM; Dunn J; Walker W; Wanic K; Moczulski D; Canani L; Araki S; Makita Y; Warram JH; Krolewski AS
    Diabetes; 2008 Sep; 57(9):2519-26. PubMed ID: 18559660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes.
    Maeda S; Imamura M; Kurashige M; Araki S; Suzuki D; Babazono T; Uzu T; Umezono T; Toyoda M; Kawai K; Imanishi M; Hanaoka K; Maegawa H; Uchigata Y; Hosoya T
    Clin Exp Nephrol; 2013 Dec; 17(6):866-71. PubMed ID: 23543049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes.
    Germain M; Pezzolesi MG; Sandholm N; McKnight AJ; Susztak K; Lajer M; Forsblom C; Marre M; Parving HH; Rossing P; Toppila I; Skupien J; Roussel R; Ko YA; Ledo N; Folkersen L; Civelek M; Maxwell AP; Tregouet DA; Groop PH; Tarnow L; Hadjadj S
    Diabetologia; 2015 Mar; 58(3):543-8. PubMed ID: 25476525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.
    Pezzolesi MG; Katavetin P; Kure M; Poznik GD; Skupien J; Mychaleckyj JC; Rich SS; Warram JH; Krolewski AS
    Diabetes; 2009 Nov; 58(11):2698-702. PubMed ID: 19651817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes.
    Pezzolesi MG; Poznik GD; Skupien J; Smiles AM; Mychaleckyj JC; Rich SS; Warram JH; Krolewski AS
    Kidney Int; 2011 Jul; 80(1):105-11. PubMed ID: 21412220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.
    Fagerholm E; Ahlqvist E; Forsblom C; Sandholm N; Syreeni A; Parkkonen M; McKnight AJ; Tarnow L; Maxwell AP; Parving HH; Groop L; Groop PH;
    Diabetologia; 2012 Sep; 55(9):2386-93. PubMed ID: 22643932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
    Craig DW; Millis MP; DiStefano JK
    Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study for diabetic nephropathy genes in African Americans.
    McDonough CW; Palmer ND; Hicks PJ; Roh BH; An SS; Cooke JN; Hester JM; Wing MR; Bostrom MA; Rudock ME; Lewis JP; Talbert ME; Blevins RA; Lu L; Ng MC; Sale MM; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Kidney Int; 2011 Mar; 79(5):563-72. PubMed ID: 21150874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New susceptibility loci associated with kidney disease in type 1 diabetes.
    Sandholm N; Salem RM; McKnight AJ; Brennan EP; Forsblom C; Isakova T; McKay GJ; Williams WW; Sadlier DM; Mäkinen VP; Swan EJ; Palmer C; Boright AP; Ahlqvist E; Deshmukh HA; Keller BJ; Huang H; Ahola AJ; Fagerholm E; Gordin D; Harjutsalo V; He B; Heikkilä O; Hietala K; Kytö J; Lahermo P; Lehto M; Lithovius R; Osterholm AM; Parkkonen M; Pitkäniemi J; Rosengård-Bärlund M; Saraheimo M; Sarti C; Söderlund J; Soro-Paavonen A; Syreeni A; Thorn LM; Tikkanen H; Tolonen N; Tryggvason K; Tuomilehto J; Wadén J; Gill GV; Prior S; Guiducci C; Mirel DB; Taylor A; Hosseini SM; ; Parving HH; Rossing P; Tarnow L; Ladenvall C; Alhenc-Gelas F; Lefebvre P; Rigalleau V; Roussel R; Tregouet DA; Maestroni A; Maestroni S; Falhammar H; Gu T; Möllsten A; Cimponeriu D; Ioana M; Mota M; Mota E; Serafinceanu C; Stavarachi M; Hanson RL; Nelson RG; Kretzler M; Colhoun HM; Panduru NM; Gu HF; Brismar K; Zerbini G; Hadjadj S; Marre M; Groop L; Lajer M; Bull SB; Waggott D; Paterson AD; Savage DA; Bain SC; Martin F; Hirschhorn JN; Godson C; Florez JC; Groop PH; Maxwell AP
    PLoS Genet; 2012 Sep; 8(9):e1002921. PubMed ID: 23028342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.
    Sambo F; Malovini A; Sandholm N; Stavarachi M; Forsblom C; Mäkinen VP; Harjutsalo V; Lithovius R; Gordin D; Parkkonen M; Saraheimo M; Thorn LM; Tolonen N; Wadén J; He B; Osterholm AM; Tuomilehto J; Lajer M; Salem RM; McKnight AJ; ; Tarnow L; Panduru NM; Barbarini N; Di Camillo B; Toffolo GM; Tryggvason K; Bellazzi R; Cobelli C; ; Groop PH
    Diabetologia; 2014 Aug; 57(8):1611-22. PubMed ID: 24871321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC
    Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.
    Savage DA; Patterson CC; Deloukas P; Whittaker P; McKnight AJ; Morrison J; Boulton AJ; Demaine AG; Marshall SM; Millward BA; Thomas SM; Viberti GC; Walker JD; Sadlier D; Maxwell AP; Bain SC
    Diabetologia; 2008 Nov; 51(11):1998-2002. PubMed ID: 18773191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis of podocyte slit diaphragm genes as candidates for diabetic nephropathy.
    Ihalmo P; Wessman M; Kaunisto MA; Kilpikari R; Parkkonen M; Forsblom C; Holthöfer H; Groop PH;
    Diabetologia; 2008 Jan; 51(1):86-90. PubMed ID: 17968527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.